The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.

about

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.

Item

http://www.wikidata.org/entity/Q55100898

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

The effectiveness of transarte ...... ngiocarcinoma after resection.

@en

The effectiveness of transarte ...... ngiocarcinoma after resection.

@nl

type

Item

label

The effectiveness of transarte ...... ngiocarcinoma after resection.

@en

The effectiveness of transarte ...... ngiocarcinoma after resection.

@nl

prefLabel

The effectiveness of transarte ...... ngiocarcinoma after resection.

@en

The effectiveness of transarte ...... ngiocarcinoma after resection.

@nl

P1476

The effectiveness of transarte ...... angiocarcinoma after resection

@en

P2093

Danbi Lee

http://www.w3.org/2001/XMLSchema#string

Gwang Hyeon Choi

http://www.w3.org/2001/XMLSchema#string

Kang Mo Kim

http://www.w3.org/2001/XMLSchema#string

Seong Kyun Na

http://www.w3.org/2001/XMLSchema#string

Yong Moon Shin

http://www.w3.org/2001/XMLSchema#string

Young-Hwa Chung

http://www.w3.org/2001/XMLSchema#string

Young-Suk Lim

http://www.w3.org/2001/XMLSchema#string

Yung Sang Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Combined hepatocellular cholangiocarcinoma: Controversies to be addressed

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.

Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.

Management of combined hepatocellular and cholangiocarcinoma.

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.

P304

e0198138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0198138

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ju Hyun Shim

Jihyun An

Han Chu Lee

P577

2018-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29879137

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

5991684

http://www.w3.org/2001/XMLSchema#string